id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-1149-0018,FDA,FDA-2016-N-1149,Testimony from American Association of Neurological Surgeons and Congress of Neurological Surgeons,Other,Testimony,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T21:10:43Z,,0,0,09000064823ba7a1
FDA-2016-N-1149-0013,FDA,FDA-2016-N-1149,Testimony from Advanced Medical Technology Association (AdvaMed),Other,Testimony,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T20:15:59Z,,0,0,0900006482381f85
FDA-2016-N-1149-0012,FDA,FDA-2016-N-1149,Testimony from Biotechnology Innovation Organization (BIO),Other,Testimony,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T20:14:51Z,,0,0,090000648238157d
FDA-2016-N-1149-0022,FDA,FDA-2016-N-1149,Testimony from Jerome Lew,Other,Testimony,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T21:30:38Z,,0,0,09000064823f9294
FDA-2016-N-1149-0014,FDA,FDA-2016-N-1149,Testimony from National Women's Health Network,Other,Testimony,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T20:23:47Z,,0,0,0900006482397fc5
FDA-2016-N-1149-0011,FDA,FDA-2016-N-1149,Testimony from Floyd Abrams,Other,Testimony,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T19:38:38Z,,0,0,0900006482364d05
FDA-2016-N-1149-0008,FDA,FDA-2016-N-1149,"Transcript of Day 1 on November 9, 2016",Other,Transcript(s),2016-12-13T05:00:00Z,2016,12,2016-12-13T05:00:00Z,,2016-12-13T17:12:36Z,,0,0,09000064824016af
FDA-2016-N-1149-0009,FDA,FDA-2016-N-1149,"Transcript of Day 2 on November 10, 2016",Other,Transcript(s),2016-12-13T05:00:00Z,2016,12,2016-12-13T05:00:00Z,,2016-12-13T17:13:48Z,,0,0,09000064824016b0
FDA-2016-N-1149-0006,FDA,FDA-2016-N-1149,Testimony from MMpiHer Consulting,Other,Testimony,2016-10-26T04:00:00Z,2016,10,2016-10-26T04:00:00Z,,2016-10-26T16:02:52Z,,0,0,090000648234f639
FDA-2016-N-1149-0001,FDA,FDA-2016-N-1149,Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products; Public Hearing; Request for Comments,Proposed Rule,Notice of Hearing,2016-09-01T04:00:00Z,2016,9,2016-09-01T04:00:00Z,2017-04-20T03:59:59Z,2017-04-21T01:02:02Z,2016-21062,0,0,09000064821bd14a